Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

T gamma delta lymphocytes

Single hepatic intra arterial administration of increasing doses of T gamma delta lymphocytes

Trial Locations (3)

35000

Unité de Thérapie Cellulaire, Laboratoire de Cytogénétique et Biologie Cellulaire, CHU Rennes, Rennes

35042

Département d'Oncologie Médicale - CRLCC Eugène Marquis, Rennes

Unknown

Service de Chirugie Viscérale - Hôpital de Pontchaillou, Rennes

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Innate Pharma

INDUSTRY

lead

Rennes University Hospital

OTHER

NCT00562666 - Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells | Biotech Hunter | Biotech Hunter